Lifespot Health (LSH) Stock Price, News & Analysis

Company Overview

Lifespot Health Ltd provides diagnostic systems and delivery platforms to healthcare enterprises in Australia. The company is developing the BodyTel System that integrates multiple sensors for capturing diagnostic information for additional diseases; Seng-Vital, a Bluetooth enabled vaporizer and health platform designed for the use of medical cannabis; and FeverTel, a dual mode digital thermometer to record and track family's symptoms. Lifespot Health Ltd was incorporated in 2016 and is based in Melbourne, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 120,633 shs
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Diagnostics & Research
• Sub-Industry: Transportation
• Current Symbol: ASX:LSH
• CIK: N/A
• Web: www.lifespot-health.com
• Phone: 61 3 9191 0135
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 7.16
• Quick Ratio: 6.93

Sales & Book Value

• Annual Sales: $22,476.00
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 2.71
• Book Value: A$0.02 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 168,467,008
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A